Building and Sustaining Winning Competitive Intelligence Organizations

Research Info
Building and Sustaining Winning Competitive Intelligence Organizations
Download FREE Excerpt
ID: SM-175
Price: $7,995.00
Pages: 132
Questions? Call
Jason Pendse
919-403-0251 x255
Features:
 40+ Info Graphics
 90+ Data Graphics
 500+ Metrics
 50+ Narratives
 17 Best Practices
Delivery Format:
 Shipped
Buy this research as part of a !
In today’s fast changing business environment, the competitive intelligence organization can play a vital role in corporate success by helping companies anticipate and deploy strategic responses to external threats and opportunities. CI, however, is a relatively new corporate function, is often not fully understood, and is often underdeveloped and undervalued.
This study can help executives learn how top corporate competitive intelligence organizations use data to drive strategy and market success. To determine how best-in-class companies proactively manage their CI functions to sustain efficiency and profitability, Best Practices, LLC researched several major topic areas: (1) creating and communicating CI value, (2) optimal structure and alignment, (3) resource levels, (4) key primary and secondary intelligence.

Best Practices, LLC completed this study in two phases involving a total of 54 different companies representing more than a dozen different industries. Each phase involved a survey instrument as well as separate in-depth telephone interviews with selected CI program executives. Surveys were focused on collecting quantitative data, while interviews collected qualitative data and management insights.


Sales and Marketing > Marketing Management


Download Free Excerpt

View TOC and List of Exhibits

Study Snapshot

Key Findings
d Industries Profiled:
Biotech; Pharmaceutical; Aerospace; Banking; Financial Services; Computers; High Tech; Manufacturing; Consumer Products; Health Care; Telecommunications; Professional Services

Companies Profiled:
Amgen; Sanofi-aventis; Boehringer-Ingelheim; Boeing; Centocor; Citigroup; EDS; Eli Lilly; Fidelity Investments; IBM; Kraft; Merck; Motorola; Novartis; Procter & Gamble; Raytheon; Roche; Rockwell Collins; Shire Pharmaceuticals; Takeda; Trane; Weyerhaeuser; Wyeth

Study Snapshot

This research is focused on several major topic areas: (1) creating and communicating CI value, (2) optimal structure and alignment, (3) resource levels, (4) key primary and secondary intelligence sources, (5) high impact CI activities, and (6) effective stakeholder relationships. Specific areas of coverage include:


· Tactics for increasing CI value and recognition
· Current and ideal departmental alignment for maximum effectiveness
· Operating budget levels and trends
· Average compensation and bonus potential for CI staff by individual job level
· Outsourcing of CI activities
· Practices for gathering intelligence from internal and external customers
· Top five most impactful activities
· Average numbers of company products supported and competitor products tracked
· Methods for building trust with internal customers and collaborators
· Most effective internal communication approaches
· Essential skills, experiences and attributes for employee success in CI roles
· Program performance measurement

Back to Top

Key Findings

Among the findings that emerged from this research are the following:

Best organizational fit: Organizational placement or “fit” of the CI function significantly impacts its ability to influence and engage decision makers. Strategic planning and business development are the locations most often cited by study participants as desirable departmental homes.
Customer focus: High performing CI organizations operate within a framework that emphasizes customer focus to shape projects that have maximum impact. Top organizations target and serve critical customer segments that have the greatest impact on the business, personally engage with these customers to understand their business needs, and become instrumental in providing intelligence to inform their customers’ most important decisions. World class CI groups understand the specific needs of each customer and create custom deliverables to meet their individual requirements.
External customers: External customers are a rich source of competitive intelligence because they talk with competitors and receive competitor product pricing and features information on a continuous basis. Customers also use competitor products and can identify weaknesses in them. However, tapping into this rich resource is a challenge for most CI groups.

Back to Top



Related Research:

Building and Sustaining Winning Competitive Intelligence Organizations 
In today’s fast changing business environment, the competitive intelligence organization can play a vital role in corporate success by helping companies anticipate and deploy strategic responses to external threats and opportunities... (ID SM-175)
Companies Profiled: Amgen, Sanofi-aventis, Boehringer-Ingelheim, Boeing, more ...
Price: $7995.00   Free Excerpt Available


Launching Pharmaceutical Megabrands: Best Practices in Marketing Blockbusters 
The findings in this Best Practices Benchmarking® Report will enable pharmaceutical executives to understand the winning strategies, practices, team structures and investment patterns that distinguish successful new product development and marketing planning... (ID SM-124)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, Bristol-Myers Squibb, Amgen, more ...
Price: $7962.00   Free Excerpt Available


Developing the High-Performance Market Research Function 
Market research departments increasingly face this challenge to their primary roles: evolving from providers of support-level data to highly-valued business advisors for strategic decision-making... (ID SM-169)
Companies Profiled: AstraZeneca, Sanofi-aventis, Zurich North American, Towers Perrin, more ...
Price: $7949.00   Free Excerpt Available


Pharmaceutical New Product Commercialization: Preparing for Market Success 
Long and costly product development cycles make it essential for pharmaceutical companies to maximize limited staff and resources to the development of compounds with the greatest potential market value... (ID SM-176)
Companies Profiled: Abbott, Allergan, Alexion Pharmaceuticals, Altus Biologics, more ...
Price: $7795.00   Free Excerpt Available


Managing the Competition: Turning Competitive Intelligence into Strategy 
Learn how top corporate competitive intelligence organizations use competitor data to drive strategy and market success... (ID SM-157)
Companies Profiled: 3M Pharmaceuticals, Abbott Laboratories, Amgen, AstraZeneca, more ...
Price: $7502.00   Free Excerpt Available


Best Practices in Working with Patient Advocacy Groups: Building Effective Relationships 
Patient and professional advocacy groups play a crucial role in educating the marketplace on new medicines and treatments... (ID SM-185)
Companies Profiled: Abaxis, Abbott Laboratories, Allos Therapeutics, Amgen, more ...
Price: $7500.00   Free Excerpt Available


Raising Disease State Awareness: Best Practices in Internal Brand Messaging for New Products 
Educating the marketplace about disease state is crucial to the success of a new pharmaceutical product— especially if the product treats a medical condition that is previously unknown, socially sensitive or stigmatized or if the product is first in its class... (ID OP-106)
Companies Profiled: Abbott, Novartis, Actelion, Novo Nordisk, more ...
Price: $7200.00   Free Excerpt Available


Educating the Market: Creating Value Through Support of Continuing Medical Education 
As new therapies emerge, physicians and consumers alike face not only expanded treatment options but also the attendant challenge of choosing the most appropriate drug... (ID SM-180)
Companies Profiled: Alcon, Sanofi-Aventis, Amylin, AstraZeneca, more ...
Price: $6995.00   Free Excerpt Available


Collaborating with Patient Advocacy Groups to Educate the Marketplace 
Strong relationships with advocacy groups are fundamental for educating the public on most recent medical happenings, especially on socially-sensitive conditions and treatment options... (ID PSM-242)
Companies Profiled: Abbott Laboratories, Baxter Healthcare, Solvay Pharmaceuticals, Vital Therapies, more ...
Price: $6500.00   Free Excerpt Available


Clinical Trial Excellence: The Science & Art of Winning Investigators in a Competitive Marketplace 
In facing the dual challenge of recruiting investigators who will deliver patients and add credibility to their trials, clinical operations executives within pharmaceutical companies and CROs have had to develop sophisticated techniques to find, screen and win the support of investigators... (ID OP-94)
Companies Profiled: Amersham, Sanofi-aventis, ALTANA Pharmaceuticals, Amgen, more ...
Price: $6500.00   Free Excerpt Available


Educating The Market: Creating Value Through Support of Continuing Medical Education 
STUDY OVERVIEW With limited information on actual return on investment for expenditures toward support of Continuing Medical Education activities, Pharmaceutical and Biotechnology companies are anxious to understand the value of CME support and strategies for ensuring investments provide appropriate impact on healthcare practitioner behaviors and patient outcomes... (ID PSM-223)
Companies Profiled: Alcon Laboratories, Sanofi-aventis, Wyeth Pharmaceuticals, TAP, more ...
Price: $5995.00   Free Excerpt Available


Government Affairs & Public Policy Excellence: Optimizing Group Structure & Operations 
Businesses today face tougher regulations and scrutiny, which necessitates strong Government Affairs and Public Policy groups that can direct and oversee complex matters in regards to public policy and legislation... (ID PSM-252)
Companies Profiled: Abbott, DRI, Novo Nordisk, Biomarin, more ...
Price: $5600.00   Free Excerpt Available


From Breakthrough to Blockbuster: Best Practices in Communicating Clinical Trial Results 
Pharmaceutical companies spend considerable resources conducting large clinical studies to support the launch of new products or expand indications for currently marketed products... (ID SM-166)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, AstraZeneca, Bristol-Myers Squibb, more ...
Price: $5362.00   Free Excerpt Available


Competitive Intelligence Policies, Ethics and Data Collection: Navigating the Gray Zone 
In today’s fast-changing, high-pressure marketplace, the Competitive Intelligence (CI) function helps companies anticipate external threats and opportunities in a timely manner so companies can respond strategically... (ID SM-179)
Companies Profiled: Alcon Labs, Sanofi-aventis, Biogen Idec, Centocor, more ...
Price: $5352.00   Free Excerpt Available


Optimizing Key Opinion Leader Relationships: Best Practices in KOL Management 
Study Overview The advocacy of Key Opinion Leaders (KOLs) has proven to be among of the most effective and critical means of building product awareness in the medical and scientific communities... (ID PSM-235)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, URL Pharma, Transoma Medical, more ...
Price: $5200.00   Free Excerpt Available


Advocacy Excellence: Optimizing Group Structure & Operations 
Alliances with patient advocacy groups play an important role in educating the marketplace about new and existing therapies... (ID PSM-253)
Companies Profiled: Abbott, Genomic Health, Boehringer Ingelheim, Amgen, more ...
Price: $5100.00   Free Excerpt Available


Patient Advocacy & Professional Organizations: Building Effective Relationships 
Study these winning practices to gain a deeper understanding of how leading companies interact with patient advocacy and professional organizations to create lasting relationships and partner for successful activities... (ID SM-156)
Companies Profiled: Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, more ...
Price: $4950.00   Free Excerpt Available


Product Re-Launch Excellence: Transforming Lackluster Pharmaceutical Products Into Market Success Stories 
Product re-launch is the hobgoblin of the pharmaceutical and biotech sector... (ID SM-170)
Companies Profiled: Bayer Healthcare, Sanofi-aventis, UCB Pharma, Schering-Plough, more ...
Price: $4651.00   Free Excerpt Available


Understanding Managed Markets: Effective Market Research Structures & Activities to Maximize Payers Access & Insights 
Today’s physicians are rapidly losing their influence over patients’ drug utilization decisions and unfortunately a large number of bio-pharmaceutical companies have failed to recognize that third-party payers, such as government and commercial organizations, now control the vast majority of prescription drug expenditures... (ID SM-183)
Companies Profiled: Amgen, Johnson & Johnson, Alcon, Solvay Pharmaceuticals, more ...
Price: $4600.00   Free Excerpt Available


Pharmaceutical New Product Commercialization: Preparing for Market Success 
Long and costly product development cycles make it essential for pharmaceutical companies to maximize limited staff and resources to the development of compounds with the greatest potential market value... (ID PSM-227)
Companies Profiled: Abbott, Allergan, Alexion Pharmaceuticals, Altus Biologics, more ...
Price: $4595.00   Free Excerpt Available



All contents copyright 1998-2010 Best Practices, LLC (919) 403-0251
Site Map | Read our Privacy Policy.